Hong Kong-listed WuXi Biologics’ proposed spin-off and Hong Kong listing of shares in subsidiary WuXi XDC has moved into pre-marketing, according to reports. In June, WuXi Biologics, a global Contract Research, Development,…
Hong Kong-listed WuXi Biologics’ proposed spin-off and Hong Kong listing of shares in subsidiary WuXi XDC has moved into pre-marketing, according to reports. In June, WuXi Biologics, a global Contract Research, Development,…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference